Contrast-enhanced Ultrasound as a Screening Tool for Kidney Cancer in Patients With Von-Hippel Lindau
Status:
Recruiting
Trial end date:
2022-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if contrast-enhanced ultrasound can detect abnormal
features of kidney lesions in patients with Von-Hippel Lindau with the same accuracy as
conventional ultrasound and contrast-enhanced magnetic resonance imaging (MRI)